SCHEMBL785463

SCHEMBL785463

Cc1cc(N2CCC(CN(C)C(=O)c3ccc4c(c3)CC[C@H]4N3Cc4cccc(Cl)c4C3=O)CC2)ccn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 3/20 0.35
GHSR Q92847 2/20 0.34
F2 P00734 1/20 0.34
PLAT P00750 1/20 0.34
KLKB1 P03952 1/20 0.34
LDHA P00338 1/20 0.34
BDKRB1 P46663 1/20 0.34
CHRM1 P11229 1/20 0.32
CYP11B2 P19099 1/20 0.32
PDK1 Q15118 1/20 0.31
PDK2 Q15119 1/20 0.31
PDK3 Q15120 1/20 0.31
PDK4 Q16654 1/20 0.31
ESR1 P03372 1/20 0.31
CRBN Q96SW2 1/20 0.31
MAPK1 P28482 1/20 0.31
ABL1 P00519 2/20 0.31
PDGFRB P09619 2/20 0.31
KIT P10721 2/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL784312 0.81 GHSR (0.32) F10GHSRF2PLATKLKB1
SCHEMBL785735 0.80 BDKRB1 (0.43) F10GHSRBDKRB1
SCHEMBL784476 0.77 OPRD1 (0.37) GHSR
SCHEMBL784121 0.75 BDKRB1 (0.42) F10GHSRBDKRB1
SCHEMBL785563 0.74 TAS1R3 (0.40) F10LDHABDKRB1KMT2A
SCHEMBL784812 0.73 PARP1 (0.47)
SCHEMBL784220 0.73 PARP1 (0.38) BDKRB1
SCHEMBL785795 0.72 CRBN (0.42) CRBN
SCHEMBL2816152 0.72 CRBN (0.42) CRBN
SCHEMBL785723 0.72 CRBN (0.42) CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US claimed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US claimed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 F10 524/4885GHSR 600/4885F2 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.